Erkan Y. Osman - Concepedia

Author

Erkan Y. Osman

University of Missouri ORCID

Also Known As

E Y Osman, E. Y. Osman, E.Y. Osman, Erkan Osman, Erkan Y Osman, Erkan Y. Osman, Osman, Erkan Y.

Publications

947

Citations

H-Index

Concepts

All Affiliations

University of Missouri Missouri College University of Southern California University of Edinburgh Columbia University

About

Erkan Y. Osman is an author at University of Missouri specializing in medicine, gene expression, and social sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	198
2	Social Sciences	4	4	150
3	Cell Biology	4	4	129
4	Biomedical Engineering	1	1	28
5	Cellular Physiology	1	1	63

Erkan Y. Osman

Publications

941

Citations

H-Index

Page 1

	Year	Citations
Delivery of Therapeutic Agents Through Intracerebroventricular (ICV) and Intravenous (IV) Injection in Mice Jacqueline Glascock, Erkan Y. Osman, Tristan H. Coady, Journal of Visualized Experiments	2011	119
Delivery of bifunctional RNAs that target an intronic repressor and increase SMN levels in an animal model of spinal muscular atrophy Travis D. Baughan, Amy L. Dickson, Erkan Y. Osman, Human Molecular Genetics	2009	111
Bifunctional RNAs Targeting the Intronic Splicing Silencer N1 Increase SMN Levels and Reduce Disease Severity in an Animal Model of Spinal Muscular Atrophy Erkan Y. Osman, Pei–Fen Yen, Christian L. Lorson Molecular Therapy	2011	66
Plastin-3 extends survival and reduces severity in mouse models of spinal muscular atrophy Kevin A. Kaifer, Eric Villalón, Erkan Y. Osman, JCI Insight	2017	65
A Negatively Acting Bifunctional RNA Increases <i>Survival Motor Neuron</i> Both <i>In Vitro</i> and <i>In Vivo</i> Alexa Dickson, Erkan Y. Osman, Christian L. Lorson Human Gene Therapy Molecular BiologyTherapeuticsSynaptic SignalingCellular PhysiologyBifunctional Rnas	2008	63
Morpholino antisense oligonucleotides targeting intronic repressor Element1 improve phenotype in SMA mouse models Erkan Y. Osman, Madeline R. Miller, Kate L. Robbins, Human Molecular Genetics	2014	62
Defining the therapeutic window in a severe animal model of spinal muscular atrophy Kate L. Robbins, Jacqueline Glascock, Erkan Y. Osman, Human Molecular Genetics	2014	60
Decreasing Disease Severity in Symptomatic, <i>Smn</i> <sup>−/−</sup> ; <i>SMN2</i> <sup>+/+</sup> , Spinal Muscular Atrophy Mice Following scAAV9-SMN Delivery Jacqueline Glascock, Erkan Y. Osman, Mary J. Wetz, Human Gene Therapy	2011	53
Enhancement of <scp>SMN</scp> protein levels in a mouse model of spinal muscular atrophy using novel drug‐like compounds Jonathan J. Cherry, Erkan Y. Osman, Matthew C. Evans, EMBO Molecular Medicine	2013	46
Rescue of a Mouse Model of Spinal Muscular Atrophy With Respiratory Distress Type 1 by AAV9-IGHMBP2 Is Dose Dependent Monir Shababi, Zhihua Feng, Eric Villalón, Molecular Therapy	2016	41

Page 1